Martin Taylor
Principal·F-Prime
Cambridge, MA, United States
Martin Taylor is a Principal at F-Prime focused on biotechnology investment and company creation across oncology, cardiovascular, renal and metabolic diseases, and rare disease. He joined F-Prime's London office in 2019 and has worked on biotechnology company creation efforts and investments in Europe, including ARTBIO, CHARM Therapeutics, and Tenpoint Therapeutics. Before F-Prime, he was a Wellcome Trust Sir Henry Wellcome Postdoctoral Fellow at the MRC Laboratory of Molecular Biology.
See the rest of Martin Taylor's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.